The National Institute of Neurological Disorders and Stroke of the National Institutes of Health has awarded a grant to Akelos Inc. to help the biopharmaceutical
The North Carolina Department of Health and Human Services updated the state’s dental opioid action plan to help dentists prevent the misuse of opioids. The
Supplemental regional anesthesia may reduce opioid use in patients following microvascular free flap reconstruction of the oral cavity, according to a study published in the
Though U.S. oral and maxillofacial surgeons decreased overall opioid prescribing by 20% between 2016 and 2019, they wrote more prescriptions for codeine and tramadol, according
A dentist’s decision whether or not they will prescribe opioids is influenced by several factors and their personal experiences. Researchers identified 10 major factors that
The ADA is partnering with the Drug Enforcement Administration to present a free three-part webinar series available for both dentists and the dental team. Part
Social: ADA Board of Trustees and New Dentists Committee members enjoy an April 9 social outing at a Chicago entertainment venue. Some of the dental
Born in Havana in 1954, Bernard Fialkoff, D.D.S., immigrated with his family to the U.S. in 1962 to flee political oppression. “From an early age
Mehran Mehrabi, D.M.D., M.D. Mehran Mehrabi, D.M.D., M.D. The ADA Council on Dental Practice is presenting a free webinar on June 8 to raise awareness
A combination of the opioid class drug tramadol and nonsteroidal anti-inflammatory drug (NSAID) dexketoprofen proved more effective than ibuprofen alone for managing pain after third-molar
Dear Anesthesia & Pain Management Insider, A combination of the opioid class drug tramadol and nonsteroidal anti-inflammatory drug (NSAID) dexketoprofen proved more effective than ibuprofen
The National Institute of Dental and Craniofacial Research (NIDCR) recently unveiled a funding opportunity announcement (FOA) that will support interventions and programs to prevent, reduce,
